Similarly, rare variants in the GBA gene encoding glucocerebrosidase (previously described as a potential risk factor of cognitive impairment in Parkinson's disease) are also overrepresented in patients with FTD-ALS and ALScbi compared to patients with ALS and having no cognitive impairment (78). This evidence concerns the gene GBA1 and Parkinson disease.